News for '-v-2'

Indica V2 Xeta cheaper by Rs 25,000

Indica V2 Xeta cheaper by Rs 25,000

Rediff.com15 Nov 2006

Tata Motors has launched an introductory limited period price-off offer of Rs 25,000 on the new 1.2 litre engine option to the Indica V2 Xeta range.

Covid virus can linger in human body for over 1 year, finds study

Covid virus can linger in human body for over 1 year, finds study

Rediff.com8 Mar 2024

The researchers from the University of California, San Francisco found pieces of SARS-CoV-2, referred to as COVID antigens, lingering in the blood up to 14 months after infection and for over two years in tissue samples from people who had COVID-19.

Over 30% Covaxin takers reported adverse events: Study

Over 30% Covaxin takers reported adverse events: Study

Rediff.com16 May 2024

Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 vaccine in adolescents and adults, claimed.

Rising cases of JN.1 subvariant: Here's what WHO said

Rising cases of JN.1 subvariant: Here's what WHO said

Rediff.com18 Dec 2023

In the wake of the surge in respiratory diseases and new JN.1 sub-variant of COVID-19, the World Health Organisation (WHO) said that the virus is evolving and changing and urged the member states to continue with strong surveillance and sequence sharing.

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.

Nilekani-backed people+ai rolls out AI strategy...

Nilekani-backed people+ai rolls out AI strategy...

Rediff.com8 May 2024

An initiative of Nandan Nilekani's EkStep Foundation, people+ai on Tuesday unveiled its vision for the future of Artificial Intelligence (AI) in India, dubbed 'Adbhut India' (Amazing India). It aims to harness AI as a powerful tool to enhance the lives of all Indians. The event marked the rollout of several initiatives by people+ai that are focused on discovering, demonstrating, and disseminating population-scale AI use cases for India.

No need for concern about Covid sub-variant JN.1: Kerala health minister

No need for concern about Covid sub-variant JN.1: Kerala health minister

Rediff.com17 Dec 2023

George said this was detected months ago in Indian passengers who were screened at Singapore Airport.

JN.1 sub-variant spreads across 15 states, 923 cases reported

JN.1 sub-variant spreads across 15 states, 923 cases reported

Rediff.com11 Jan 2024

COVID-19 sub-variant JN.1 has spread to 15 states and Union territories with a total of 923 cases of the infection reported so far, according to the Indian SARS-CoV-2 Genomics Consortium (INSACOG).

India's Covid sub-variant JN.1 tally rises to 169; highest from Kerala, Guj

India's Covid sub-variant JN.1 tally rises to 169; highest from Kerala, Guj

Rediff.com29 Dec 2023

Several states have been reporting an uptick in the number of COVID cases over the last few weeks and nine states and Union territories have so far detected the presence of the JN.1 sub-variant of the virus.

Covid: WHO classifies Eris as 'variant of interest'

Covid: WHO classifies Eris as 'variant of interest'

Rediff.com10 Aug 2023

The World Health Organisation (WHO) has classified the EG.5 strain of the SARS-CoV-2 virus circulating in different parts of the world, including India, as a 'variant of interest' but said it did not seem to pose more of a threat to public health than other strains.

Kerala woman found infected with Covid sub-strain JN.1

Kerala woman found infected with Covid sub-strain JN.1

Rediff.com16 Dec 2023

A case of COVID-19 sub-variant JN. 1 has been detected in Kerala as part of an ongoing routine surveillance activity of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a senior official from the Indian Council of Medical research (ICMR) said on Saturday.

Maharashtra reports 50 new Covid cases; 9 of them JN.1 infections

Maharashtra reports 50 new Covid cases; 9 of them JN.1 infections

Rediff.com24 Dec 2023

Of the fresh cases, nine were caused by JN.1, increasing the number of infections tied to the new sub-variant in the state to 10, it said.

263 cases of sub-variant JN.1 found in India

263 cases of sub-variant JN.1 found in India

Rediff.com2 Jan 2024

A total of 263 cases of COVID-19 sub-variant JN.1 have been detected in the country so far, with about half of them recorded in Kerala, according to the Indian SARS-CoV-2 Genomics Consortium (INSACOG)'s data updated on Tuesday.

Amid JN.1 scare, Karnataka reports 2 Covid deaths

Amid JN.1 scare, Karnataka reports 2 Covid deaths

Rediff.com21 Dec 2023

Two Covid-19 related deaths and 20 fresh cases were reported in Karnataka, according to a Health bulletin issued on Wednesday.

Autopsies show Covid virus lingers in body parts for months: Study

Autopsies show Covid virus lingers in body parts for months: Study

Rediff.com3 Jan 2023

The study showed that SARS-CoV-2 primarily infected and damaged airway and lung tissue.

1,226 cases of JN.1 found in India so far, Karnataka, Andhra top list

1,226 cases of JN.1 found in India so far, Karnataka, Andhra top list

Rediff.com18 Jan 2024

A total of 1,226 cases of COVID-19 sub-variant JN.1 have been reported in the country so far with Karnataka and Andhra Pradesh recording the highest number of cases till now, according to the Indian SARS-CoV-2 Genomics Consortium (INSACOG) on Thursday.

Pneumonia outbreak in China: Centre asks states to...

Pneumonia outbreak in China: Centre asks states to...

Rediff.com26 Nov 2023

The Union health ministry has advised states to immediately review public health preparedness in view of recent reports indicating a surge in respiratory illness in children in northern China.

22 cases of JN.1 found so far, Kerala woman recovers

22 cases of JN.1 found so far, Kerala woman recovers

Rediff.com22 Dec 2023

Twenty-two cases of COVID-19 sub-variant JN.1 have been detected in the country till Thursday, with 21 cases being reported from Goa and another from Kerala, official sources said.

iBall CompBook Premio v2.0: A power laptop at an affordable price

iBall CompBook Premio v2.0: A power laptop at an affordable price

Rediff.com7 May 2018

Priced at 21,999, this 14-inch device is as fair a deal as they come.

'New Covid surge is a seasonal wave but spreads faster'

'New Covid surge is a seasonal wave but spreads faster'

Rediff.com18 Mar 2024

'Seek medical help if after five days of the first symptom the fever has not subsided.'

Centre alerts states, UTs as country sees surge in Covid cases

Centre alerts states, UTs as country sees surge in Covid cases

Rediff.com18 Dec 2023

In a letter to states and Union Territories, Union health secretary Sudhansh Pant underlined that "due to consistent and collaborative actions between the Centre and state governments, we have been able to sustain the (COVID-19) trajectory at sustainable low rates".

Does India have enough vaccine reserves to combat another Covid wave?

Does India have enough vaccine reserves to combat another Covid wave?

Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.

Eye disease drug may stop reproduction of coronavirus, says study

Eye disease drug may stop reproduction of coronavirus, says study

Rediff.com9 Nov 2022

Signalling pathways are complicated chain reactions which control many important human biological processes and in which certain proteins act as messenger molecules that promote or block the signals of other proteins.

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

Covid's XBB.1.5 variant cases rise to 7 in India

Covid's XBB.1.5 variant cases rise to 7 in India

Rediff.com6 Jan 2023

Of the seven cases, three were found in Gujarat and one each in Karnataka, Telangana, Chhattisgarh and Rajasthan, Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.

How UPI v2.0 will change your life

How UPI v2.0 will change your life

Rediff.com22 Aug 2018

For financial institutions, it will be an opportunity to provide better lending options. For instance, customers who pay their overdrafts on time will get access to more credit and probably at a cheaper rate.

Centre's letter to states amid Covid spike in US, China

Centre's letter to states amid Covid spike in US, China

Rediff.com20 Dec 2022

In a letter to states and UTs, Union Health Secretary Rajesh Bhushan said such an exercise will enable timely detection of newer variants, if any, circulating in the country and will facilitate undertaking of requisite public health measures.

Women twice as likely as men to suffer from long Covid, says US study

Women twice as likely as men to suffer from long Covid, says US study

Rediff.com19 Oct 2022

Researchers at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, US, estimate that globally 63 per cent of those with long Covid during the first two years of the pandemic were female.

Covid may damage brain like Parkinson's disease

Covid may damage brain like Parkinson's disease

Rediff.com20 Jun 2022

COVID-19 patients commonly report symptoms such as brain fog, headaches, and insomnia, complications which are not new after a viral infection, the researchers said.

Common cold T cells may offer Covid protection: Study

Common cold T cells may offer Covid protection: Study

Rediff.com10 Jan 2022

The researchers believe their findings provide a blueprint for a second-generation, universal vaccine that could prevent infection from current and future SARS-CoV-2 variants, including Omicron.

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

Rediff.com5 Aug 2022

One in eight adults who are infected with SARS-CoV-2 experience long term symptoms due to Covid-19, according to one of the most comprehensive studies on the viral disease to date published in The Lancet journal on Friday.

Scientists developing chewing gum that could reduce Covid spread

Scientists developing chewing gum that could reduce Covid spread

Rediff.com6 Dec 2021

The researchers noted that people who are fully vaccinated can still become infected with SARS-CoV-2 and can carry a viral load similar to those who are unvaccinated.

Covid originated in animals at Wuhan market and spread to humans: Studies

Covid originated in animals at Wuhan market and spread to humans: Studies

Rediff.com28 Feb 2022

The first study used spatial analysis to show that the earliest known COVID-19 cases, diagnosed in December 2019, were centered on the Wuhan market.

Omicron infects 70 times faster than Delta: Study

Omicron infects 70 times faster than Delta: Study

Rediff.com16 Dec 2021

However, the severity of illness is likely to be much lower, according to a study.

With quota politics is Modi playing V P Singh v2.0?

With quota politics is Modi playing V P Singh v2.0?

Rediff.com9 Jan 2019

'Rather than 'consolidate' the Hindu majority votes, as the BJP-RSS combine has been known and wont to try, this time round PM Modi has himself taken the party to the next step, by seeking to create a new divide within the majority community, a la V P Singh in his time.'

SIIto test Novavax's Omicron-specific vaccine

SIIto test Novavax's Omicron-specific vaccine

Rediff.com6 Jun 2022

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.

Want To Buy This E-Bike For Rs 1.09 Lakh?

Want To Buy This E-Bike For Rs 1.09 Lakh?

Rediff.com28 Apr 2023

Vader is the first electric bike in India to offer 7-inch Android display.

New test can predict your level of immunity against COVID-19

New test can predict your level of immunity against COVID-19

Rediff.com10 Aug 2022

Easy access to this kind of test could help people determine what kind of precautions they should take against COVID-19 infection, such as getting an additional booster shot, the researchers said.

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

India 'Stay Calm' About Kraken: Experts

India 'Stay Calm' About Kraken: Experts

Rediff.com16 Jan 2023

The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.